Wall Street Zen downgrades Cardinal Health stock from Strong Buy to Buy

Published on 10/20/2026 at 11:37 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Fiscal 2027 guidance is USD 12.40-12.60 per share. Cardinal Health stock costs EUR 225.90 on October 20, 2026, ahead of November 5 results.

Rating change and fiscal outlook

Wall Street Zen changed its Cardinal Health rating on October 17, 2026.
Fiscal 2027 guidance is USD 12.40-12.60 per share.
Cardinal Health stock trades at EUR 225.90 at 11:33 a.m. CEST at Lang & Schwarz on October 20, 2026.

Isometrische 3D-Illustration der Pharma-Lieferkette von Produktion bis Apotheke — Isometrisches 3D-Diagramm der Lieferkette von Cardinal Health Inc. – Medizinprodukte ISIN US14149Y1082, Illustration mit AI erstellt.

Cardinal Health (ISIN US14149Y1082) was trading at EUR 225.90 at Lang & Schwarz on October 20, 2026 at 11:33 a.m. CEST. The latest analyst action came from Wall Street Zen, which moved its rating from strong-buy to buy on October 17, 2026, according to MarketBeat.

Three milestones shape the picture

Cardinal Health reported quarterly earnings on August 11, 2026. Revenue for the quarter reached USD 63.67 billion, up 5.80 percent from the prior-year quarter, while earnings per share came to USD 2.91 against a USD 2.42 consensus estimate, according to MarketBeat.

On October 1, 2026, Cardinal Health entered a binding letter of intent to extend its pharmaceutical distribution agreements with CVS Health through June 30, 2032. The same date, the company said it would report first-quarter fiscal 2027 results on November 5, 2026, before trading opened on the New York Stock Exchange, in its Cardinal Health release.

What does the guidance mean?

Cardinal Health set fiscal 2027 guidance at USD 12.40-12.60 in earnings per share. The range gives investors a quantified benchmark for the November 5 report, while the latest quarter combined a 5.80 percent revenue increase with a USD 0.49 earnings-per-share beat against consensus, as MarketBeat reported.

Next date for investors

The next substantiated company date is November 5, 2026, when Cardinal Health plans to publish first-quarter fiscal 2027 results before the NYSE opens. The company scheduled an 8:30 a.m. Eastern webcast for the results discussion, according to Cardinal Health.

Stock remains near its yearly high

Cardinal Health is listed on the NYSE under ticker CAH. Its USD 58.5 billion market capitalization and USD 156.81 to USD 258.30 52-week range are dated October 19, 2026, while the stock's Lang & Schwarz quote places it below the reported yearly high in the US market data.

Cardinal Health was trading at EUR 225.90 at Lang & Schwarz on October 20, 2026 at 11:33 a.m. CEST. The further course of trading is shown by the continuously updated real-time quote of Cardinal Health stock.